OncoSNIPE® artificial intelligence project officially launched

October 18, 2017

  • A structural competitiveness project (PSPC) under the “Investments for the Future Programme” coordinated by Oncodesign
  • Integration of UNICANCER, grouping together all the French Comprehensive Cancer Centres (FCCCs), into the consortium
  • Favorable opinion from the CPP (French Ethical Review Board) authorizing a longitudinal clinical trial in oncology


Oncodesign announces the acquisition of Bertin Pharma’s pharmaceutical and biotech services businesses

  • Oncodesign is expanding its service offering in immunology and infectious diseases
  • It is gaining additional capacity for studying the ADME1 profile of therapeutic molecules, in regulated bioanalysis and in biobanking
  • The acquisition will contribute to the Oncodesign group’s revenue growth from September 1, 2017 onwards